← Back to blog

BREATHING CONVERSATIONS

Prof. Luca Richeldi discusses clinical and scientific developments in the field of pulmonology

In recent years, however, research is opening a new phase in pulmonology: that of targeted biologics. Among the most promising targets is interleukin-33 (IL-33), a molecule that could redefine the treatment of COPD.

BPCO-AND ANTI–IL-33: THE REVOLUTION OF 'UPSTREAM' Biologics

BREATHING CONVERSATIONS

Read article →

Prof. Luca Richeldi, a leading expert on pulmonary fibrosis

Published on May 6, 2026

A vaccine against pulmonary fibrosis: science fiction or near future?

BREATHING CONVERSATIONS

Read article →

Damage cause by inhaling toxic substances

Published on May 6, 2026

Harm caused by inhalation of toxic substances: from the acute event to the risk of fibrosis

BREATHING CONVERSATIONS

Read article →

immunopeptidome in a pulmonary fibrosis

Published on April 22, 2026

Immunopeptidome profiling in pulmonary fibrosis provides a platform for identifying therapeutic targets

BREATHING CONVERSATIONS

Read article →

the artificial intelligence revolution

Published on April 16, 2026

Respiratory diagnosis via smartphone: the artificial intelligence revolution in clinical practice

BREATHING CONVERSATIONS

Read article →

cystic fibrosis

Published on April 3, 2026

Artificial Intelligence and Pulmonary Fibrosis

BREATHING CONVERSATIONS

Read article →

treatments for severe asthma

Published on April 3, 2026

Tezepelumab and severe asthma

BREATHING CONVERSATIONS

Read article →

artificial intelligence and the lungs

Published on April 3, 2026

Artificial Intelligence and Respiratory Diagnostics

BREATHING CONVERSATIONS

Read article →

public health

Published on March 30, 2026

When Politics Gets into Pulmonology: How Public Decisions Influence Respiratory Health

BREATHING CONVERSATIONS

Read article →

Spirometry

Published on March 9, 2026

When to perform spirometry: what it is used for and when it is truly indicated

BREATHING CONVERSATIONS

Read article →

Doctor Rx scan image

Published on March 9, 2026

Pulmonary fibrosis: life expectancy and how treatments are changing

BREATHING CONVERSATIONS

Read article →